Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Phenylethylamine in paranoid chronic schizophrenia.

Literature DB >> 504988

Phenylethylamine in paranoid chronic schizophrenia.

S G Potkin, F Karoum, L W Chuang, H E Cannon-Spoor, I Phillips, R J Wyatt.

Abstract

Phenylethylamine (PEA) is an endogenous amine that is structurally and pharmacologically related to amphetamine. Urinary PEA excretion is significantly higher in paranoid chronic schizophrenics than in nonparanoid chronic schizophrenics and normal controls. Diet, hospitalization, and medication do not account for differences in PEA concentrations. These findings offer some indication that PEA may be an endogenous amphetamine.

Entities: Chemical Disease

Mesh：

Substances：
Phenethylamines

Year: 1979 PMID： 504988 DOI： 10.1126/science.504988

Source DB: PubMed Journal: Science ISSN： 0036-8075 Impact factor: 47.728

Keyword Cloud
Cited

22 in total

Review 1. Receptors of mammalian trace amines.

Authors: Anita H Lewin
Journal: AAPS J Date: 2006-03-10 Impact factor: 4.009

2. S(+)amphetamine induces a persistent leak in the human dopamine transporter: molecular stent hypothesis.

Authors: Aldo A Rodriguez-Menchaca; Ernesto Solis; Krasnodara Cameron; Louis J De Felice
Journal: Br J Pharmacol Date: 2012-04 Impact factor: 8.739

3. New high-performance liquid chromatographic procedure for the detection and quantification of beta-phenylethylamine.

Authors: F Gusovsky; K A Jacobson; K L Kirk; T Marshall; M Linnoila
Journal: J Chromatogr Date: 1987-03-20

4. Behavioral sensitization to beta-phenylethylamine (PEA): enduring modifications of specific dopaminergic neuron systems in the rat.

Authors: T Kuroki; T Tsutsumi; M Hirano; T Matsumoto; Y Tatebayashi; K Nishiyama; H Uchimura; A Shiraishi; T Nakahara; K Nakamura
Journal: Psychopharmacology (Berl) Date: 1990 Impact factor: 4.530

5. Inhibition of monoamine oxidases by haloperidol and its metabolites: pharmacological implications for the chemotherapy of schizophrenia.

Authors: J Fang; P H Yu; J W Gorrod; A A Boulton
Journal: Psychopharmacology (Berl) Date: 1995-03 Impact factor: 4.530

6. Urinary phenylethylamine correlates positively with hypomania, and negatively with depression, paranoia, and social introversion on the MMPI.

Authors: H W Moises; P Waldmeier; H Beckmann
Journal: Eur Arch Psychiatry Neurol Sci Date: 1986

Phenylethylamine in paranoid chronic schizophrenia.

Review 1. Receptors of mammalian trace amines.

2. S(+)amphetamine induces a persistent leak in the human dopamine transporter: molecular stent hypothesis.

3. New high-performance liquid chromatographic procedure for the detection and quantification of beta-phenylethylamine.

4. Behavioral sensitization to beta-phenylethylamine (PEA): enduring modifications of specific dopaminergic neuron systems in the rat.

5. Inhibition of monoamine oxidases by haloperidol and its metabolites: pharmacological implications for the chemotherapy of schizophrenia.

6. Urinary phenylethylamine correlates positively with hypomania, and negatively with depression, paranoia, and social introversion on the MMPI.

7. A pharmacological analysis of the hyperactivity syndrome induced by beta-phenylethylamine in the mouse.

8. Electrophysiological Actions of Synthetic Cathinones on Monoamine Transporters.

Review 9. Trace amine-associated receptor 1-Family archetype or iconoclast?

10. Phenylethylamine and monoamine metabolites in CSF of schizophrenics: effects of neuroleptic treatment.